New therapies for severe meningococcal disease but better outcomes?

Lancet

Volumn 350, Issue 9091, 1997, Pages 1565-1566

  Duncan, A ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CYTOKINE; ENDOTOXIN; HEPARIN; PROTEIN C;

ADOLESCENT; ADULT; AMPUTATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FIBRINOLYTIC THERAPY; FULMINATING PURPURA; HUMAN; INFANT; INFLAMMATION; MENINGOCOCCOSIS; MORTALITY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; SEPTIC SHOCK; SEPTICEMIA; SHORT SURVEY;

EID: 0031556852     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64007-X     Document Type: Note

References (10)

1. Giroir BP, Quint PA, Barton P et al. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability - increasing protein in children with severe meningococcal sepsis. Lancet 1997; 350: 1439-43.
2. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-IA. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 1994; 121: 1-5.
3. Fijnvandraat K, Derkx B, Peters M, et al. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.
4. Rivard GE, David M, Farrell C, Schwarz HP.Treatment of purpura fulminans in meningococcaemia with protein C concentrate. J Pediatr 1995; 126: 646-52.
5. van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW. Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis 1992; 15: 424-30.
6. Goldman AP, Kerr SJ, Butt W, et al. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349: 466-69.
7. Bellomo R,Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-26.
8. Fourrier F, Chopin C, Huart JJ et al. Double blind placebo controlled trial of ATIII concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104: 882-88.
9. Keeley SR, Matthews NT, Buist M.Tissue plasminogen activator for gangrene in fulminant meningococcaemia. Lancet 1991; 337: 1359.
10. Zenz W, Muntean W, Gallistl S, et al. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcaemia. Pediatrics 1995; 96: 144-47.